Paul Karatzas
Hello, you found Paul Karatzas, MBA a Medical Device Sales Leader!
With over 10 years of experience in sales leadership. Paul Karatzas has a strong understanding of market dynamics, customer needs, and emerging trends in healthcare technology. Prior to joining his position at DIH technology as Vice President, Paul held key positions with leading Dental Implant companies, where his expertise in creating and implementing successful sales strategies significantly contributed to year over year revenue growth. With a remarkable career marked by consistent achievements and a deep technical understanding of the dental industry and human anatomy, Paul played a pivitol role in driving Noris Medical’s sales strategy and market expansion by doubling annual revenue year over year. Noris Medical experienced tremendous expansion into new markets from 2020-2022 via education and new sales to DSO’s. Paul’s ability to forge strong relationships with key stakeholders, including dentists, oral surgeons, periodontist, and dental laboratories, has been instrumental in establishing Noris Medical as a leading trusted partner in the dental implant industry. Recognized as an industry expert in dentistry, biologics, and sales, with an in-depth knowledge of the latest technologies, market trends, and competitive landscape, Paul’s commitement to staying at the forfront of advancements was instrumental in positioning Noris Medical as a leader in the field of atrophic jaws. Today, Paul Karatzas possesses a deep understanding of the challenges and opportunities within the neuro rehabilitation robotics space. His passion for advancing healthcare through cutting edge technologies has been a driving force in establishing DIH Technology as the market leader in the field. He has forged strategic partnerships, fostered innovation, and expanded the company’s foot print in the neuro rehab market for the Americas. As the Vice President of DIH, Paul Karatzas is dedicated to driving innovation and shaping the future of healthcare. He is committed to expanding the brand, fostering his alliances, and leveraging emerging technologies in his pipeline to enhance the effectiveness and accessibility for patients.